ArticleCancers2022

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer.

Astrid E Slagter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.